This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Opportunities in the Japanese Therapeutic Drug Monitoring (TDM) Market? is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
This unique report from VPGMarketResearch provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments ...
September 2015 | $2100 | View Details >>
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.SummaryThis comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology and flow cytometry markets during the next five years. The ...
January 2017 | $0 | View Details >>
This unique report from VPGMarketResearch provides Europe sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, ...
November 2015 | $7800 | View Details >>
The Global Isothermal Nucleic Acid Amplification Technology (INAAT) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Isothermal Nucleic Acid Amplification Technology (INAAT) industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The ...
April 2016 | $2800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research